[Federal Register Volume 68, Number 92 (Tuesday, May 13, 2003)]
[Notices]
[Pages 25615-25616]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-11877]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee and 
subcommittee meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2:15 p.m., June 3, 2003; 8:30 a.m.-3 
p.m., June 4, 2003.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 a.m. and 8:30 a.m. or 12:30 p.m. 
and 1 p.m. Entrance to the meeting at other times during the day 
cannot be assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters to be Discussed: Agenda items will include: a report 
from the National Vaccine Program Office (NVPO); an update on the 
Smallpox Vaccination Program; a report from the Acting Assistant 
Secretary for Health; an update on vaccine supply issues; a report 
from the polio vaccine stockpile workgroup; a report on the 
Institute of Medicine (IOM) Vaccine Safety Review Committee; a 
report from the IOM on their review of the Smallpox Vaccination 
Program; a report from the Influenza Immunization Summit; an update 
on pandemic influenza planning; a report from the Immunization 
Coverage Subcommittee, the Future Vaccines Subcommittee, and the 
Vaccine Safety and Communication Subcommittee; a discussion of 
compensation for vaccine administration; a discussion on Enhancing 
Public Participation in Immunization Decision-Making; a report from 
the Workgroup on Public Health Options for Implementing Immunization 
Recommendations; a report from the Polio Laboratory Containment 
Workgroup; a discussion of monitoring anthrax vaccine adverse events 
using the Department of Defense Medical Surveillance System; reports 
from the Advisory Commission on Childhood Vaccines/Division of 
Vaccine Injury Compensation, the Vaccine Related Biological Products 
Advisory Committee/Food and Drug Administration, and the Advisory 
Committee on Immunization Practices/National Immunization Program/
National Center for Infectious Diseases.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
    Place: Hubert H. Humphrey Building, Room 405A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters to be Discussed: Agenda items will include an update on 
the proposed pneumococcal meeting; an update on the newborn 
vaccination meeting; CMV status report; and a presentation on Group 
A Steptococcus vaccines.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
    Place: Hubert H. Humphrey Building, Room 705A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee identifies and proposes solutions 
that provide a multifaceted and holistic approach to

[[Page 25616]]

reducing barriers that result in low immunization coverage for 
children.
    Matters to be Discussed: Agenda items will include an update on 
publication of the newly revised Adult and Pediatric Immunization 
Standards; a discussion of adolescent immunization; Immunization 
Registries--Updates on the use of VFC funds for registry development 
standards of excellence; PCV7 update on impact of shortage on 
coverage and active bacterial core surveillance; a discussion of the 
draft report from the Workgroup on Public Health Options for 
Implementing Immunization Recommendations; updates on pneumococcal 
and influenza coverage; and a review of data on the burden of 
pneumococcal disease.

    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 2:30 p.m.-5 p.m., June 3, 2003.
    Place: Hubert H. Humphrey Building, Room 425A, 200 Independence 
Avenue, SW., Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters to be Discussed: Next Steps in Risk Communication: 
Reviews of IOM Immunization Safety Review Committee Recommendations, 
and of NVPO Workshop Recommendations; a discussion of the influenza 
communications programs; a discussion of next topics for the IOM 
Safety Review Committee; a review of the National Immunization 
Program Website; and, an update on thimerosal-related litigation.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria Sagar, Committee 
Management Specialist, NVPO, CDC, 4700 Buford Highway M/S K-77, 
Chamblee, Georgia 30341, telephone 770/488-2040.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 7, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-11877 Filed 5-12-03; 8:45 am]
BILLING CODE 4163-18-P